Close

Acorda Therapeutics (ACOR) Tops Q3 EPS by 23c

October 31, 2013 6:44 AM EDT Send to a Friend
Acorda Therapeutics (NASDAQ: ACOR) reported Q3 EPS of $0.36, $0.23 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login